Disclosed are novel inorganic acid salts of sibutramine, which have good physicochemical properties, and crystalline forms thereof. Also disclosed are pharmaceutical compositions comprising the compounds as effective ingredients, methods of preparing the compounds, and the use of the compounds.

 
Web www.patentalert.com

> Morpholine derivatives as norepinephrine reuptake inhibitors

~ 00371